Janssen triumphs again in battle to protect HIV drug patents
Angela McDonald 2021-05-24 10:24 am By Cat Fredenburgh | Melbourne
Please login to bookmark Close

Juno Pharmaceuticals has backed away from its plans to launch a generic version of HIV drug Prezista in Australia after being hit with a patent lawsuit by Janssen, becoming the second generic drug maker to capitulate to the Johnson & Johnson-owned company’s demands.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au